跳至主要内容
临床试验/NCT00824148
NCT00824148已完成不适用

Use of Real-time Continuous Glucose Monitoring System to Control Blood Glucose in Patients With Type 1 Diabetes Mellitus

Norwegian University of Science and Technology2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Level of HbA1c concentration

研究概览

简要总结

The purpose of this study is to determine whether a real-time continuous glucose monitoring system is able to improve HbA1c in patients suffering from type 1 diabetes compared to conventional finger prick glucose measurements. In addition it will investigate whether number of episodes with serious hypoglycemia is changed in those same patients, and whether quality of life (health status and treatment satisfaction) increases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes Mellitus, Type 1 > 3 years.
  • For practical reasons patients should live in Trondheim, Malvik, Melhus or Klæbu.
  • Level of HbA1c (measured by DCA 2000) between 7 and 10 % and/or experience blood glucose < 3 mmol/L (verified by finger-prick measurement) at least once a week and/or at least one episode with serious hypoglycemia the previous half a year.(Defined as need of help from others)
  • Only patients who use insulin pumps or multi-injection regime (=3 daily injections with short term acting insulin or insulin analogue + at lest one daily injection with NPH-insulin or long term acting insulin analogue.

排除标准

  • Patients with other diseases such as untreated hypothyroidism, adrenal gland failure, celiac disease, renal failure, unstable coronary heart disease, serious psychiatric disorder, or mental retardation.
  • Patients who are not able to learn how to use the continuous glucose monitoring system given a reasonable amount of effort.
  • Patients who are not able to do the glucose measurements, insulin dose change and diary notes which the study demands.
  • Unsuited for participating from any other cause.

结局指标

主要结局

Level of HbA1c concentration

时间窗: 1 and 3 months post intervention.

次要结局

  • Quality of life assessed by SF-36, DTSQs and DTSQc(1 and 3 months post intervention)
  • Number of hypoglycemic events(1 and 3 months post intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验